Emergent Biosolutions Inc (EBS): Next-Year EPS Estimate 261.33%
As of 2026-11-12, Emergent Biosolutions Inc (EBS) has a next-year EPS growth estimate of 261.33%. Featured in 3 EPS revision reports, most recently on 2026-08-29.
On 2026-11-03, analyst consensus for EBS's next-year EPS growth shifted from 190.99% to 261.33% — a positive change of 70.34 percentage points. The revised estimate has been sustained across 9 subsequent trading sessions. Current-year growth is projected at -81.07%.
What's Driving This
The primary
Generated 2026-11-11 from news as of 2026-11-10
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 261.33%
- EPS growth this year
- -81.07%
- EPS next quarter (est)
- -$0.16
- Last price
- $5.89
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-11-12 | 261.33% | -81.07% | -$0.16 | $5.89 |
| 2026-11-11 | 261.33% | -81.07% | -$0.16 | $6.04 |
| 2026-11-10 | 261.33% | -81.07% | -$0.16 | $6.05 |
| 2026-11-09 | 261.33% | -81.07% | -$0.16 | $6.10 |
| 2026-11-07 | 261.33% | -81.07% | -$0.16 | $6.06 |
| 2026-11-06 | 261.33% | -81.07% | -$0.16 | $6.06 |
| 2026-11-05 | 261.33% | -81.07% | -$0.16 | $5.85 |
| 2026-11-04 | 261.33% | -81.07% | -$0.16 | $5.90 |
| 2026-11-03 | 261.33% | -81.07% | -$0.16 | $6.25 |
| 2026-11-02 | 190.99% | -76.50% | -$0.08 | $6.44 |
| 2026-10-31 | 190.99% | -76.50% | -$0.39 | $6.81 |
| 2026-10-30 | 190.99% | -76.50% | -$0.39 | $6.81 |
| 2026-10-29 | 190.99% | -76.50% | -$0.39 | $7.22 |
| 2026-10-28 | 190.99% | -76.50% | -$0.39 | $7.09 |
| 2026-10-27 | 190.99% | -76.50% | -$0.39 | $6.67 |
| 2026-10-26 | 190.99% | -76.50% | -$0.39 | $6.34 |
| 2026-10-23 | 190.99% | -76.50% | -$0.39 | $6.23 |
| 2026-10-22 | 190.99% | -76.50% | -$0.39 | $6.23 |
| 2026-10-21 | 190.99% | -76.50% | -$0.39 | $6.20 |
| 2026-10-20 | 190.99% | -76.50% | -$0.39 | $6.29 |
| 2026-10-19 | 190.99% | -76.50% | -$0.39 | $6.36 |
| 2026-10-16 | 190.99% | -76.50% | -$0.39 | $6.38 |
| 2026-10-15 | 190.99% | -76.50% | -$0.39 | $7.18 |
| 2026-10-14 | 190.99% | -76.50% | -$0.39 | $6.91 |
| 2026-10-13 | 190.99% | -76.50% | -$0.39 | $6.91 |
| 2026-10-12 | 190.99% | -76.50% | -$0.39 | $6.98 |
| 2026-10-11 | 190.99% | -76.50% | -$0.39 | $7.06 |
| 2026-10-10 | 190.99% | -76.50% | -$0.39 | $7.06 |
| 2026-10-09 | 190.99% | -76.50% | -$0.39 | $7.06 |
| 2026-10-08 | 190.99% | -76.50% | -$0.39 | $6.81 |
Reports Featuring EBS
Recent News
- Emergent BioSolutions Inc. Q1 2026 Earnings Call SummaryMoby
- Emergent BioSolutions Inc (EBS) Q1 2026 Earnings Call Highlights: Strong Revenue and Strategic ...GuruFocus.com
- Emergent Biosolutions: Q1 Earnings SnapshotAssociated Press
- Emergent BioSolutions Reports First Quarter 2026 Financial ResultsGlobeNewswire
Screen Performance
Aggregate stats across all 2145 tickers our top-EPS-revision screen has flagged over the past 225 days.
- Median return since detection
- -2.9%
- % of tickers in the green
- 43%
- Median return on winners
- +22.8%
- Large revisions captured
- 2246
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Emergent Biosolutions Inc's next-year EPS growth estimate?▾
As of 2026-11-12, Emergent Biosolutions Inc (EBS) has a next-year EPS growth estimate of 261.33%, based on analyst consensus.
When was the latest EPS estimate revision for EBS?▾
The most recent revision occurred on 2026-11-03, when analysts adjusted the next-year EPS growth estimate from 190.99% to 261.33%.
What sector and industry does Emergent Biosolutions Inc belong to?▾
Emergent Biosolutions Inc operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. EBS appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Emergent Biosolutions Inc (EBS) appears here because it was detected by our daily top-EPS-revision-performer screen.